Curis to Release First Quarter 2017 Financial Results and Hold Conference Call on May 4, 2017
LEXINGTON, Mass., April 28, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment of human cancers, today announced that the Company will release its first quarter 2017 financial results on Thursday, May 4, 2017, before the U.S. financial markets open. The Company's management will also host a conference call on the same day at 8:30 a.m. EDT.
To access the live conference call, please dial (877) 868-1829 from the United States or (253) 237-1135 from other locations, shortly before 8:30 a.m. EDT. The conference ID number is 11306169. The conference call can also be accessed on the Curis website at www.curis.com in the Investors section.
About Curis, Inc.
For more information, visit Curis's website at www.curis.com.
For More Information: James E. Dentzer Chief Financial Officer & Chief Administrative Officer Curis, Inc. 617-503-6500 email@example.com Media Contact: David Schull Russo Partners 212-845-4271 firstname.lastname@example.org